Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese and Caucasian Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06179537
What this trial is testing

Evaluation of the Pharmacokinetics and Safety of BLU-5937 in Healthy Adult Japanese and Caucasian Subjects

Who this might be right for
Healthy
Bellus Health Inc. - a GSK company 34
Early research (Phase 1)Study completedNCT03150108
What this trial is testing

Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult Subjects

Who this might be right for
Hypoparathyroidism
Shire 24
Early research (Phase 1)Study completedNCT02207790
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Adult Male Japanese and White Subjects

Who this might be right for
Healthy Subjects
Eisai Inc. 32
Early research (Phase 1)Study completedNCT01424163
What this trial is testing

Dexpramipexole Japanese PK Study

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 57
Early research (Phase 1)WithdrawnNCT01691872
What this trial is testing

Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects

Who this might be right for
Epilepsy, Partial
GlaxoSmithKline
Early research (Phase 1)Study completedNCT01761526
What this trial is testing

Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects

Who this might be right for
Healthy
UCB BIOSCIENCES GmbH 50
Early research (Phase 1)Study completedNCT01167868
What this trial is testing

Assess the Safety, Tolerability, and Blood and Urine Drug Levels of Fostamatinib Disodium (FosD) in Healthy Japanese and White Subjects

Who this might be right for
Healthy
AstraZeneca 56
Early research (Phase 1)Study completedNCT04497883
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Maribavir Administered in Healthy Japanese Participants Compared With Matched, Healthy, Non-Hispanic, Caucasian Participants and to Assess Dose-Proportionality of 3 Doses of Maribavir in Japanese Participants

Who this might be right for
Healthy Volunteers
Shire 24
Early research (Phase 1)Study completedNCT03586570
What this trial is testing

Evaluate How Aprocitentan is Safe and How it is Absorbed and Broken Down in the Body of Japanese and Caucasian Subjects

Who this might be right for
Healthy Subjects
Idorsia Pharmaceuticals Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT03310021
What this trial is testing

A Healthy Volunteer Pharmacokinetics (PK)/Pharmacodynamics (PD), Safety and Tolerability Study of Andexanet in Healthy Japanese and Caucasian Subjects

Who this might be right for
Bleeding
Portola Pharmaceuticals 108
Early research (Phase 1)Study completedNCT02161588
What this trial is testing

A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian Subjects

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Healthy
Novo Nordisk A/S 48
Early research (Phase 1)Study completedNCT01958047
What this trial is testing

Assess the Effect of Race on How a Single Dose of ASP3652 is Taken up, Metabolized and Distributed Through the Bodies of Young, Healthy Male and Female Subjects, and Its Safety and Tolerability

Who this might be right for
PharmacokineticsPharmacodynamicsHealthy Subjects+1 more
Astellas Pharma Europe B.V. 64
Early research (Phase 1)Study completedNCT01442532
What this trial is testing

The Safety and Pharmacokinetics of JNJ-38518168 in Japanese and Caucasian Male Participants and the Effect of JNJ-38518168 on the Blood Levels of Midazolam

Who this might be right for
Healthy Male Volunteer
Janssen Research & Development, LLC 94
Early research (Phase 1)Study completedNCT05056246
What this trial is testing

Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants

Who this might be right for
Healthy Participants
Amgen 34
Early research (Phase 1)Study completedNCT03579940
What this trial is testing

Lasmiditan in Healthy Japanese and Caucasian Participants

Who this might be right for
Healthy
Eli Lilly and Company 27
Early research (Phase 1)Study completedNCT04052360
What this trial is testing

Single Oral Dose of 4 mg Cenerimod in Healthy Japanese and Caucasian Subjects

Who this might be right for
Healthy Volunteers
Viatris Innovation GmbH 20
Early research (Phase 1)Study completedNCT00416546
What this trial is testing

Safety of AEB071 in Healthy Volunteers and to Compare the Ethnicity, Metabolic, and Safety Effects Between Caucasian and Japanese Healthy Subjects

Who this might be right for
Healthy
Novartis 96
Early research (Phase 1)Ended earlyNCT03375606
What this trial is testing

Assessing the Safety and Tolerability of CSL730 in Healthy Caucasian and Japanese Adults

Who this might be right for
Healthy
CSL Behring 26
Early research (Phase 1)Study completedNCT02387866
What this trial is testing

PK and Safety Study of AG-221 in Healthy Male Japanese Subjects and Healthy Male Caucasian Subjects

Who this might be right for
Healthy
Celgene 62
Early research (Phase 1)Study completedNCT01251731
What this trial is testing

Single and Multiple Dose Asian Bridging Study

Who this might be right for
Healthy Subjects
Eisai Inc. 36
Next Page